| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436316A2 Subcellular targeting of therapeutic proteins |
| 07/14/2004 | EP1436313A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/14/2004 | EP1436311A2 Antisense oligonucleotides and methods to induce tumor cell death |
| 07/14/2004 | EP1436310A1 Antisense modulation of vascular endothelial growth factor receptor-2 expression |
| 07/14/2004 | EP1436309A2 Bgl3 beta-glucosidase and nucleic acids encoding the same |
| 07/14/2004 | EP1436308A2 Antisense modulation of il-1 receptor-associated kinase-4 expression |
| 07/14/2004 | EP1436307A1 Antisense modulation of nac expression |
| 07/14/2004 | EP1436199A1 Specimen vial sealing apparatus and method |
| 07/14/2004 | EP1436015A2 Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| 07/14/2004 | EP1436013A2 Method for inducing growth and enhancing survival of nervous tissue |
| 07/14/2004 | EP1435992A2 Chemokines as adjuvants of immune response |
| 07/14/2004 | EP1435980A1 Stratified cartilage tissue and methods to engineer same |
| 07/14/2004 | EP1435977A1 Cardiac transplantation of stem cells for the treatment of heart failure |
| 07/14/2004 | EP1435966A2 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags) |
| 07/14/2004 | EP1435789A2 Hemocyanin nucleic acids and polypeptides and related vectors, fusion proteins, conjugates, cells and methods of use |
| 07/14/2004 | EP1435787A2 Nestin-expressing hair follicle stem cells |
| 07/14/2004 | EP1435779A2 Modulation of stem cells using zinc finger proteins |
| 07/14/2004 | EP1363935A4 Ter sites and ter binding proteins |
| 07/14/2004 | EP1337625B1 Stem cells, method for expansion in vitro and use thereof |
| 07/14/2004 | EP1315793A4 Methods for culturing human lung mast cells and uses thereof |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP1220943B1 Cellular test system for investgation of metabolic activity of active forms of cytochrome P450 2D6 |
| 07/14/2004 | EP1124411A4 New plants formed by microparticle bombardment with uncharacterised dna |
| 07/14/2004 | EP0912725B1 Glycosidase enzymes |
| 07/14/2004 | EP0889907B1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 07/14/2004 | EP0814819B1 Sertoli cells as transplantation facilitator for cell transplantation |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | CN1513059A Enzymes having alpha amylase activity and method of use thereof |
| 07/14/2004 | CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512856A Microfabricated tissue as substrate for pigment epithelium transplantation |
| 07/14/2004 | CN1511950A Stress inducible promoter obtained from rice |
| 07/14/2004 | CN1511948A Method for constructing genome library |
| 07/14/2004 | CN1511594A Compound artificial skin of double side implanted two kinds of cell and its construction method |
| 07/14/2004 | CN1511593A Artificial skin containing human bone marrow mesenchymal stem cell and its construction method |
| 07/14/2004 | CN1157478C Improved barster gene |
| 07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 07/13/2004 | US6762348 Genetic control of plant growth and development |
| 07/13/2004 | US6762346 Transgenic plants and plant cells, in which an amylopectin with an altered degree of branching is synthesized |
| 07/13/2004 | US6762342 Expression vector for use in generating animal model to evaluate genetic disorders sensitivity to pain and tension |
| 07/13/2004 | US6762291 Used to modify insects and worms, or cultured cells, resulting in p53 expression or mis-expression; modified organisms or cells are used in screening assays to identify potential pesticidal agents or therapeutics that interact with p53 |
| 07/13/2004 | US6762286 Modified vitamin K-dependent polypeptides |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762053 Mammalian gamete and embryo culture media and culture media supplements |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761887 Cartilage disorders |
| 07/13/2004 | US6761883 Preferential stem cells, for use in the treatment of autoimmune and immunological defects |
| 07/13/2004 | US6761876 Methods for introducing helterologous cells into fish |
| 07/13/2004 | CA2118862C Bovine ovary cell line (frov) for virus replication |
| 07/08/2004 | WO2004057028A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 07/08/2004 | WO2004057002A2 Production of heterologous glycosylated proteins in bryophyte cells |
| 07/08/2004 | WO2004056999A1 Plant cells and plants which synthesize a starch with an increased final viscosity |
| 07/08/2004 | WO2004056990A1 Novel nitrile hydratase |
| 07/08/2004 | WO2004056979A2 Recombinant virus production for the manufacturing of vaccines |
| 07/08/2004 | WO2004056978A1 Method for the separation of cell fractions |
| 07/08/2004 | WO2004056976A2 Process for coating cell-culture support |
| 07/08/2004 | WO2004056397A1 Stimulation of hematopoiesis by ex vivo actived immune cells |
| 07/08/2004 | WO2004056309A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/08/2004 | WO2004056265A2 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 07/08/2004 | WO2004056186A1 Cell-based vegf delivery |
| 07/08/2004 | WO2004044150A3 Systems for gene targeting and producing stable genomic transgen e insertions |
| 07/08/2004 | WO2004044127A3 Stem cell populations |
| 07/08/2004 | WO2004042039B1 Induction of ctla-4 upregulation in t lymphocytes |
| 07/08/2004 | WO2004034966A3 Substances for preventing and treating autoimmune diseases |
| 07/08/2004 | WO2004029235A3 Aldehyde dehydrogenase gene |
| 07/08/2004 | WO2004027021A3 Device and methods for isolating target cells |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004021995A3 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 07/08/2004 | WO2004015081A3 Methods for treating circadian rhythm phase disturbances |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2004011621A3 Multi-step method for the differentiation of insulin positive, glucose |
| 07/08/2004 | WO2004011603A3 Functional cardiomyocytes from human embryonic stem cells |
| 07/08/2004 | WO2004009767A3 Cell therapy for regeneration |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004009758A3 Embryonic stem cell markers and uses thereof |
| 07/08/2004 | WO2004001023A3 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 07/08/2004 | WO2003104259A3 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF |
| 07/08/2004 | WO2003099233A8 Microbial conversion of glucose to para-hydroxystyrene |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | WO2003078567B1 Methods of inducing differentiation in ex vivo expanded stem cells |
| 07/08/2004 | WO2003074565A3 Peptides for use in antitumor immunotherapy |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003047331A3 Methods and apparatus for cell based screening |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | WO2002095058A3 Emission ratiometric indicators of phosphorylation |
| 07/08/2004 | WO2002090926A3 Dose response-based methods for identifying receptors having alterations in signaling |
| 07/08/2004 | WO2001022916A3 Novel hev antigenic peptide and methods |
| 07/08/2004 | US20040133949 Rice-derived high expression polypeptide chain elongation factor promoter and method of using the same |
| 07/08/2004 | US20040133943 Characterisation of gene function using double stranded RNA inhibition |
| 07/08/2004 | US20040133938 Use of lipoic acid in plant culture media |
| 07/08/2004 | US20040133935 Preparation method of donor cell for nuclear transfer using electro-stimulation and membrane antigen marker and production method of clone animal |
| 07/08/2004 | US20040133933 Medane genes and proteins |
| 07/08/2004 | US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 07/08/2004 | US20040132972 Tri-hybrid melanoma antigen |
| 07/08/2004 | US20040132691 Applying a protective coatings on stents, catheters, pacemakers, breast implants, contact lenses and shunts, from inflammatory cells and platelets to a medical device; cell culturing |
| 07/08/2004 | US20040132681 Antisense modulation of beta-site APP-cleaving enzyme 2 expression |
| 07/08/2004 | US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment |
| 07/08/2004 | US20040132646 Identification of a novel glutamine transporter |